← All I-mab filings

I-mab Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

IMAB
I-mab
SCHEDULE: NovaBridge Biosciences: Wei Fu, C-Bridge Group Boost Stake
An amendment to Schedule 13D reveals updated beneficial ownership percentages in NovaBridge Biosciences by Wei Fu and affiliated C-Bridge entities, with Mr. Fu holding 11.5%.
IMAB
I-mab
SCHEDULE: I-MAB Ownership Update: CBC Group Disclaims Everest Link
An amendment to Schedule 13D clarifies beneficial ownership of I-MAB shares by CBC Group entities and Wei Fu, explicitly disclaiming a 'group' with Everest Medicines Limited.
IMAB
I-mab
SCHEDULE: Everest Medicines Boosts I-MAB Stake to 16.1%
Everest Medicines Limited has acquired a significant stake in I-MAB, increasing its beneficial ownership to 16.1% through a recent underwritten offering.
IMAB
I-mab
SCHEDULE 13D: Major Investor Group Increases Stake in I-MAB, Files Schedule 13D
A group of investment entities and individuals, led by Wei Fu, has significantly increased their beneficial ownership in I-MAB, triggering a Schedule 13D filing with the SEC.